OCGN logo

OCGN
Ocugen Inc

154,126
Mkt Cap
$537.94M
Volume
7.32M
52W High
$1.96
52W Low
$0.515
PE Ratio
-7.57
OCGN Fundamentals
Price
$1.78
Prev Close
$1.64
Open
$1.65
50D MA
$1.49
Beta
1.60
Avg. Volume
6.41M
EPS (Annual)
-$0.1993
P/B
145.00
Rev/Employee
$42,684.21
$192.14
Loading...
Loading...
News
all
press releases
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates
Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -54.76% and +0.24%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13h ago
News Placeholder
More News
News Placeholder
Ocugen (NASDAQ:OCGN) Trading 6.6% Higher - Here's Why
Ocugen (NASDAQ:OCGN) Stock Price Up 6.6% - Time to Buy...
MarketBeat·1d ago
News Placeholder
Ocugen (NASDAQ:OCGN) Trading 2.1% Higher - Time to Buy?
Ocugen (NASDAQ:OCGN) Trading 2.1% Higher - Here's Why...
MarketBeat·7d ago
News Placeholder
Moderna (MRNA) Reports Q4 Loss, Beats Revenue Estimates
Moderna (MRNA) delivered earnings and revenue surprises of +18.75% and +2.81%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
Ocugen (NASDAQ:OCGN) Trading 12.4% Higher - Time to Buy?
Ocugen (NASDAQ:OCGN) Trading Up 12.4% - What's Next...
MarketBeat·1mo ago
News Placeholder
Ocugen (OCGN) Stock Tumbles After $22.5 Million Share Offering
Ocugen shares sank sharply Wednesday after the biotech company announces a $22.5 million underwritten offering of common stock.read more...
Benzinga·1mo ago
News Placeholder
Ocugen's (OCGN) "Buy" Rating Reiterated at Chardan Capital
Chardan Capital reissued a "buy" rating and set a $7.00 price objective on shares of Ocugen in a report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Ocugen, Inc. (NASDAQ:OCGN) Short Interest Update
Ocugen, Inc. (NASDAQ:OCGN - Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totaling 46,392,427 shares, a decline of...
MarketBeat·1mo ago
News Placeholder
Ocugen Stock Is Surging Today: What's Driving The Action?
Ocugen Inc (NASDAQ:OCGN) shares are up on Friday as the company is gaining traction following positive market sentiment.read more...
Benzinga·1mo ago
News Placeholder
Ocugen's Early Gene Therapy Data Shows 46% Drop In Vision Damage
Ocugen reports early phase 2 data showing its eye gene therapy reduced lesion growth by up to 54%, with no serious safety issues.read more...
Benzinga·1mo ago
<
1
2
...
>

Latest OCGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.